Saturn V Capital Management
Saturn V Capital Management reported 23 stocks worth $697M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are AMLX (11.9%), ALMS (11.8%) and ABVX (9.9%). Compared with Q1 2026, the fund opened new positions in TRVI, SGMT and VIR, added to AMLX, PCVX and IMMX, trimmed ALMS, ABVX and JAZZ and sold out of COGT.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  AMLX Amylyx Pharmaceuticals Inc | $83M | 11.9% | 4.6M | +274K (+6%) | 7 of 8 | |
| 2 |  ALMS Alumis Inc | $82M | 11.8% | 2.9M | −287K (−9%) | 3 of 8 | |
| 3 |  ABVX Abivax SA | $69.1M | 9.9% | 519K | −24K (−4%) | 8 of 8 | |
| 4 |  PCVX Vaxcyte Inc | $49.6M | 7.1% | 853K | +28K (+3%) | 8 of 8 | |
| 5 |  IMMX Immix Biopharma Inc | $48M | 6.9% | 4.7M | +965K (+26%) | 3 of 8 | |
| 6 |  PHVS Pharvaris N V | $45.4M | 6.5% | 1.3M | +113K (+9%) | 4 of 8 | |
| 7 |  JAZZ Jazz Pharmaceuticals PLC | $38.8M | 5.6% | 161K | −2,023 (−1%) | 5 of 8 | |
| 8 |  CELC Celcuity Inc | $38.7M | 5.5% | 370K | +88K (+31%) | 8 of 8 | |
| 9 |  IRON Disc Medicine Inc | $38.4M | 5.5% | 525K | +75K (+17%) | 8 of 8 | |
| 10 |  CADL Candel Therapeutics Inc | $34M | 4.9% | 3.3M | +407K (+14%) | 2 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 COGT Cogent Biosciences Inc | $24.1M | 627K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Saturn V Capital Management 13F FAQ
What does Saturn V Capital Management own?
Saturn V Capital Management reported 23 stocks worth $697M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are AMLX (11.9%), ALMS (11.8%) and ABVX (9.9%). The table above lists every position in the filing (the top 10 without an account).
What did Saturn V Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 3 new positions, 13 added to, 6 trimmed and 1 sold out. New positions include TRVI, SGMT and VIR. It sold all of COGT.
When will Saturn V Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Saturn V Capital Management's portfolio worth?
The Q2 2026 filing reports $697M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.